Tumor necrosis factor ot (TNF-c0, a cytokine with pleiotropic biological effects, is produced by a variety of cell types in response to induction by diverse stimuli. In this paper, TNF-c~ mRNA is shown to be highly induced in a murine T cell clone by stimulation with T cell receptor (TCK) ligands or by calcium ionophores alone. Induction is rapid, does not require de novo protein synthesis, and is completely blocked by the immunosuppressant cyclosporin A (CsA). We have identified a human TNF-c~ promoter element, g3, which plays a key role in the calciummediated inducibility and CsA sensitivity of the gene. In electrophoretic mobility shift assays, an oligonucleotide containing K3 forms two DNA protein complexes with proteins that are present in extracts from unstimulated T cells. These complexes appear in nuclear extracts only after T cell stimulation. Induction of the inducible nuclear complexes is rapid, independent of protein synthesis, and blocked by CsA, and thus, exactly parallels the induction of TNF-ot mRNA by TCR ligands or by calcium ionophore. Our studies indicate that the K3 binding factor resembles the preexisting component of nuclear factor of activated T cells. Thus, the TNF-c~ gene is an immediate early gene in activated T cells and provides a new model system in which to study CsA-sensitive gene induction in activated T cells.
T
he human TNF-o~ gene encodes a cytotoxic protein with diverse biological activities including the ability to promote T and B cell growth (1-8 and for reviews see references [9] [10] [11] . TNF-ot is produced by multiple cell types including lymphocytes after viral infection or stimulation through cellsurface receptors (12) (13) (14) (15) (16) (17) (18) (19) . In primary T cells for example, TNF-c~ mRNA is induced upon stimulation with the phorbol ester (PMA) plus activating antibodies to CD3 polypeptides (12) , which are closely associated with the TCR. TNF-c~ mRNA is also induced in T cells by stimulation with PMA alone (12, 18) , and by PMA plus calcium ionophore (12, 15) , which mimics stimulation through the TCR-CD3 complex (for reviews see references 20 and 21) .
The promoter sequences required for virus, LPS (16) , PMA (18, (22) (23) (24) (25) , and TNF-c~ induction (26) of the human TNF-o~ gene have been identified. These studies have yielded a complex picture of TNF-c~ gene regulation in that the promoter sequences required for inducibility have varied with the cell type and stimulus studied. Although the 5' flanking region of the human TNF-ot gene contains three sequences, ir K2, and 1r that match the consensus sequence for a binding site for the transcription factor NF-r,B, the induction of the human TNF-ot gene by virus, LPS, or PMA in the cell lines studied does not appear to be primarily mediated by NF-Jcb (16, 18) .
Thus, in contrast to the NF-gB-mediated inducible transcription of other promoters containing NF-IcB binding sites (for a review see reference 27), and in contrast to studies with the murine TNF-a gene in which NF-gB binding sites have been implicated in LPS induction in macrophages (28, 29) , studies of the human TNF-cr gene promoter argue against a major role for NF-KB in the virus, LPS, or PMA induction of the gene (16, 18) .
The immunosuppressive agents cyclosporin A (CsA) 1 and FKS06, inhibit the transcription of many cytokine genes in activated T cells (15, (30) (31) (32) . CsA and FK506, when complexed to their intracellular receptors (cyclophilin and FKBP, respectively), bind to and inhibit the activity of the calciumand calmodulin-dependent phosphatase calcineurin (33; for reviews see references 34 and 35) . Recent studies (36) (37) (38) (39) have suggested that calcineurin regulates the activity of at least two elements in the IL-2 gene promoter, nuclear factor of activated T cells (NFAT) and NHL2A. The nuclear factors binding to these two elements appear to be distinct: the NFAT site binds to a lymphoid-specific factor, NFAT (40) , which consists of a preexisting DNA-binding subunit (NFATp) in association with los and jun proteins (41) (42) (43) , whereas the NFIL2A site binds oct-1 and oct-2 proteins in association with an inducible octamer-associated protein, OAP-40 (44) . Calcineurin may directly dephosphorylate NFATp (45) , however its effect on the activity of the Oct-OAP complex may be more involved.
Using an untransformed murine T cell clone that responds to stimulation with antigen and TCR ligands (46, 47) , the TNF-o~ gene is shown to be one of the earliest genes transcribed after T cell activation. Induction of TNF-ol mRNA does not require de novo protein synthesis but is sensitive to CsA. Thus, the TNF-cr gene represents a new model system in which to study CsA-sensitive gene induction. We have identified a TNF-a promoter dement, K3, as a CsA-sensitive regulatory element required for TNF-o~ gene transcription in activated T cells. The requirements for induction of the It3 binding factor paraUd dosdy the requirements for induction of endogenous routine TNF-a mRNA levels: both TNF-a mRNA and the ~3 binding factor are rapidly induced by TCR ligands or by calcium ionophore alone. Their induction does not require de novo protein synthesis and is blocked by CsA. Our studies indicate that the nuclear K3 binding factor is present in unstimulated T cells and that it resembles the preexisting component of NFAT. Activation of the x3 binding factor appears to require posttranslational modification and/or translocation to the nucleus via a calciumdependent, CsA-sensitive pathway.
Materials and Methods
Cell Culture, Activation, and Transfections. The murine IL-2-dependent T cell clone At-5 (48) was grown and activated with mAbs to murine CD3e (145-2Cll; oLCD3) or to a framework determinant of the routine TCI~.-r (H57-597; TCR-cr for the times indicated in the figure legends as previously described (49) . Ionomycin (Calbiochem-Novabiochem Corp., La Jolla, CA) inductions were carried out at 100 nM or 1 #M as indicated in the figures for 30 min. Where indicated, cells were treated with 10/~M cydoheximide and 40/~M anisomycin (both from Sigma Chemical Co., St. Louis, MO) for 30 min or with 1/~M CsA (Sandoz, Vienna, Austria) before the addition of antibodies or ionomycin. The ability of cydoheximide and anisomycin to block protein synthesis under these conditions was verified by testing the effect of these reagents on the expression of the EBV lyric switch gene, BZLF1, whose transcription is dependent on de novo protein synthesis (50) . Tramfeetions were performed as described (47) and cells were activated the next day with aCD3 or ionomycin and harvested ~18 h later. Chloramphenicol acetyl transferase (CAT) assays were performed as previously described (18) .
RNA Analysis. RNA was prepared from Ar-5 cells as previously described (51) . 32P-labeled RNA probes were prepared from SP6 ~/-actin (52) and a routine TNF-o~ probe as previously described (16, 51) . RNA fragments protected from RNase cleavage were separated by eleetrophoresis on a 6% denaturing polyacryhmide gel.
Preparation of Cellular Extracts and EMSAs.
Nuclear extracts were prepared as previously described (49) . To prepare cytosolic extracts, unstimulated At-5 cells were harvested by centrifugation, washed with PBS and resuspended and lysed at a concentration of 2.5 x 107 cells/ml in a buffer containing 50 mM NaCI, 20 mM Tris, pH 7.5, 10 mM iodoacetamide, 2 mM PMSF, 0.1 mM EDTA, 25 #M leupeptin, 100 #g aprotinin, and 0.05% NP-40. The cells were first centrifuged at 200 g to remove nuclei, and then centrifuged further at 100,000 g for 60 min. The 100,000 g superuatant was then adjusted to a concentration of 1.5 M ammonium sulfate, and the predpitated proteins were collected by centrifugation at 10,000 g. The protein pellets were resuspended in a buffer containing 100 mM NaCI, 20 mM Hepes, pH 7.4, 10 mM iodoacetamide, 2 mM EDTA, 2 mM PMSF, 25 gM leupeptin, 100 gg/ml aprotinin, and 10% glycerol, and were extensively dialyzed against the same buffer without iodoacetamide and with 0.5 mM DTT. EMSAs using nuclear proteins were performed using ,,05 gg nuclear protein in a total volume of 15/~1 containing 4 mM Hepes, pH 7.4, 90 mM NaC1, 20 mM KC1, 0.08 mM EDTA, 9% glycerol, 133/~g/ml poly (dl:dC), and 0.125 ng 3ZP-labeled oligonucleotide. For competition assays, a 200-fold excess of unlabeled oligonudeotide was added to the reaction. Binding reactions were incubated on ice for 15 min. Unbound oligonucleotide and protein-oligonucleotide complexes were separated by electrophoresis at 4~ on Tris/borate/EDTA/4% acrylamide gels as described earlier (49) .
Cytosolic extracts (0.5-1 ~g protein) were assayed for DNA binding in a reaction mix containing 4 mM Hepes, pH 7.4, 100 mM NaC1, 9% glycerol, 0.7 mg/ml BSA, 17/~g/ml poly (dl:dC), and 0.125 ng 3Zp-endlabeled oligonucleotide, followed by electrophoresis under the same conditions described for nuclear extracts.
Methylation interference assays were performed as described (49) . The sequences of the synthetic oligonucleotides used in the gel shift and methyhtion interference assays were as follows: K3, ( Plasmids. The TNF-c~ promoter/CAT gene constructs and the -61 TNF-cr CAT and (~3)6-61 TNF-ot CAT constructs have been previously described (16) . The g3 mutant constructs were constructed by subeloning a TNF~ promoter fragment into M13mp18 and performing in vitro mutagenesis with a Mutagene M13 in vitro Mutagenesis Kit (Biorad Laboratories, Richmond, CA). Mutants were confirmed by dideoxy sequencing. Promoter sequences from -199 to +87 nucleotides relative to the TNF-~ transcription start site were amplified by PCR and were subeloned into the POCAT vector (53) and reconfirmed by sequencing. The wild-type -199 to + 87 TNF-c~ sequences were also subeloned in this manner, insuring that all of the constructs were isogenic. Methods. RNase mapping of TNF-ot and 3'-actin mRNA was carried out with 5 gig of total cellular RNA. A 32p. labeled mouse TNF-ot probe was used to map murine TNF-ot mRNA levels and an RNA probe complementary to the 'y-act-in gene was used as an internal control for mRNA levels as previously described (15) . The 3,-actin probe was made to have asp act one fifth of the mouse TNF-ot probe. (Left) Positions of the TNF-tx and 3,-actin protected fragments.
Results

Regulation of the Endogenous
by TCK-a ( Fig. 1, lanes 4 and 7) . This burst-in mRNA expression after c~CD3 or TCK-ot induction was associated with TNF-ot protein production as determined by TNF-ot bioactivity in an L cell killing assay (data not shown), indicating that Ar-5 ceUs are a physiological system in which to study T N F -a gene induction by immunological stimuli. Induction of TNF-c~ mRNA levels was blocked by pretreatment of the cells with CsA for 10 min before the addition of stimulus (Fig. 1 , lanes 5 and 8), but not by pretreatment of the cells with the protein synthesis inhibitors cycloheximide and anisomycin ( Fig. 1, lanes 6 and 9) . Expression of TNF-cr m R N A at 4 h after activation was also unaffected by protein synthesis inhibitors but sensitive to CsA (Fig. 1, lanes 10-18) .
Thus, induction of TNF-ot gene expression by TCR stimuli was not dependent upon de novo protein synthesis and hence can be differentiated from the induction of mKNAs encoding other CsA-sensitive genes such as IL-2 in activated T cells (40) . In a related study, TNF-c~ gene expression in activated B ceUs has been shown to occur within 30 rain of activation, does not require protein synthesis, and is sensitive to CsA (19) . Thus, the TNF-c~ gene behaves as a CsA-sensitive early response gene during activation of both T and B lymphocytes.
Ca 2 § Ion~hor~ Stimulation of T cells through the TCR
results in an increase in intracellular free calcium levels and activation of protein kinase C, and can be mimicked with a combination of calcium ionophore and phorbol esters (for a review see reference 21). CsA is known to inhibit the calciumdependent pathway of T ceU activation by inhibiting the activity of the calcium-and calmodulin-dependent phosphatase calcineurin (33) . Since the induction of TNF-c~ mRNA in activated T cells was completely sensitive to CsA (Fig. 1) , it seem probable that a calcium-dependent pathway was involved. To determine whether calcium flux in the absence of protein kinase C activation was sufficient to induce TNF-c~ m R N A levels, At-5 cells were stimulated with the calcium ionophore ionomycin. TNF-cr mRNA levels were highly induced within 30 min after stimulation with 1 #M ionomycin ( Fig. 2 A, hne 5 and Fig. 2 fected into Ar-5 cells and the cells were then stimulated with otCD3 in the presence and absence of CsA. This series of plasmids contains progressive deletions of each of the loB-like binding sites (gl, g2, and g3) in the TNF-c~ promoter (diagram, Fig. 3 A), and thus can be used to evaluate the functional contribution of these sites to TCtL-mediated activation and CsA sensitivity of the gene. The TNF-c~ CAT fusion construct containing -600 n relative to the TNF-c~ mRNA cap site was highly inducible by c~CD3 and this induction was effectively blocked when the cells were pretreated with CsA ( Fig. 3 A, lanes 1-3) . Deletion of K1 which lies between the sequences spanning -600 and -576, or deletion of K2, which lies between the sequences -242 and -199 n, had little effect on the promoter's inducibility by cr or its sensitivity to CsA (Fig. 3 A, lanes 4-12) . Deletion of the sequences between -199 and -118 n reduced the absolute values of both basal and induced CAT activity ( Fig. 3 A, lanes 13-15). However, the promoter's inducibility is not affected by the deletion of these sequences, and the -118 deletion construct was still sensitive to CsA (see Fig. 3 B) . We conclude that the sequences between -199 and -118 n contain a positive regulatory region that is required for maximal levels of induction of a linked CAT reporter gene by c~CD3.
In contrast, deletion of the sequences between -118 and -80 n, which removes the g3 element, almost eliminated otCD3 inducibility and CsA sensitivity of the TNF-c~ gene ( 
A, lanes I0-15).
Nevertheless, the -118 construct was dearly induced by ionomycin treatment and this induction was blocked by CsA (Fig. 4 , lanes 4-6). When the sequences between -118 and -80, which contain the r,3 site, were deleted, induction by ionomycin was no longer detectable (lanes 7-9). Deletion of the sequences between -600 and -199 had no effect on the ionomycin inducibility of the TNF-ot promoter (data not shown). In conclusion, these results indicate that the sequences between -199 and + 89 n relative to the TNF-c~ start site mediate induction of the gene by both TCR ligands and calcium ionophore, and that the sequences between -118 and -80 are also required for inducibility and CsA sensitivity in the case of both inducers.
The/c3 Site Functions as an Inducible, CsA-sensitive Transc@tional Element In Vivo within the Context of the TNF~Promoter
The significant drop in inducibility and CsA sensitivity of the TNF-c~ promoter seen upon deletion of the sequences between -118 and -80 suggested that these sequences contained an otCD3 and calcium-inducible, CsA-sensitive promoter element. The region defined by this deletion contained the previously characterized KB-like binding site, g3, and its surrounding sequences (spanning -106 to -87 nt relative to the TNF-ot transcription start site) (18) . To determine the importance of these sequences, (referred to as K3 or the K3 element throughout this paper), and to evaluate its in vivo function within the context of the TNF-ot promoter during T cell activation, TNF-ot promoter CAT fusion genes with base substitution mutations in the g3 site were constructed. These mutations named 5', middle, 3', and 3' flank are depicted in Fig. 5 C. They were created in the context of the -199 TNF-ol promoter (WT) and are all isogenic except for the base changes noted.
TCR Stimuli. Mutation of any of the nucleotides within the NF-gB consensus motif of the g3 site caused a reduction in the relative induction of CAT activity in response to otCD3 stimulation of transiently transfected At-5 cells. Mutations in the 5' or 3' ends of the site reduced the induction, of CAT activity to "~28% (5' M) and 44% (3' M), respectively, of the level of induction seen with the W T plasmid (Fig. 5 A) . The effect of mutating the middle nucleotides (MM), was more modest, decreasing induction to "~70% of WT levels.
In contrast, mutation of the nucleotides flanking the 3' end of the g3 site (3' flank M), did not decrease induction of CAT activity, but rather caused a slight increase in the average level of induction ('~116% of WT induced levels). These results 
Multiple Copies of the K3 Promoter Element Confer CsA-sensitive Inducibility on a Minimal TNF-ar Promoter
To further characterize the function of the K3 element and to determine whether K3 could function as a discrete regulatory dement, Ar-5 cells were transfected with a construct in which multimers of g3 were placed upstream of a minimal TNF-ot promoter fused to CAT. The control construct containing the minimal TNF-ol promoter (-61 to + 89 n) was minimally inducible by oeCD3 (approximately twofold) (Fig. 6 A, lanes 1 and 2) . In contrast, a construct that conrained six copies of the K3 dement upstream of -61 TNF-c~ CAT was dearly inducible by olCD3 (approximately sevenfold) and this augmented induction was blocked by CsA (Fig.  6 A, lanes 4-6) . The K3 multimers also conferred ionomycin inducibility on the minimal TNF-o~ promoter (from '~3-15- fold) that was blocked by CsA ( Fig. 6 B, lanes 4--6 ). In conclusion, this analysis indicated that r,3 sequences are sufiicient to mediate CsA-sensitive transcriptional induction in response to c~CD3 or ionomycin. When the K3 multimers were fused to a heterologous promoter (-128/3-globin), they did not confer either inducibility or CsA sensitivity on the CAT reporter gene (data not shown). Therefore, the K3 element behaved in T cells as an c~CD3, calcium-inducible, and CsAsensitive transcriptional promoter element in the context of its own minimal TNF-c~ gene promoter.
Rapid Protein Synthesis-ind~endent Induction of a CsA-sensitive /:3 Binding Factor(s)
in Stimulated T Cells TCR Stimuli. To further characterize the K3 element and to test whether g3 could bind to an inducible, CsA-sensitive nuclear factor in stimulated T cells, nuclear extracts were prepared from At-5 cells that had been stimulated with olCD3 in the presence and absence of CsA for the various times indicated in Fig. 7 A. Using the K3 oligonucleotide spanning the sequences from -106 to -87 n relative to the TNF-ot 
-6). (B) Ionomycin induction the ~3 binding complex is blocked by
CsA and does not require de novo protein synthesis. Nuclear extracts were prepared from Ar-5 cells that were mock induced (-), treated with CsA alone, or CHX/ANIS alone, or induced with 1/~M ionomycin in the presence or absence of CsA or CHX/ANIS as indicated. The nuclear extracts were bound to the g3 oligonucleotide or the -61 n to -27 n oligonucleotide as indicated. mRNA cap site in an EMSA, two inducible complexes (Fig.   7 , upper and lower) were detected. These complexes were apparent within 15 min of activation by cxCD3 (Fig. 7, lanes  1 and 3) , and were maximally induced at 30 min after stimulation (Fig. 7, lane 5) . By 4 h after olCD3 induction, the upper complex was barely detectable (Fig. 7, lane 11) , whereas the intensity of the lower complex was significantly decreased (Fig. 7, lane 11) . Induction of both inducible complexes was completely blocked at all time points by pretreatment of the cells with CsA (Fig. 7, lanes 4, 6, 8, and 10 ).
To determine whether induction of the r3 binding factor(s) required prior protein synthesis, nuclear extracts from At-5 cells that had been induced with oeCD3 for various times in the presence and absence of protein synthesis inhibitors were tested. As shown in Fig. 7 B, de novo protein synthesis is not required for induction of K3 binding activity since cycloheximide and anisomycin did not prevent or delay the appearance of r3 binding activity after o~CD3 induction (Fig.  7, lanes 3 and 4) . We conclude that the K3 element specificaUy binds to an aCD3-inducible, CsA-sensitive, protein synthesis-independent factor(s) that is induced within minutes of T cell activation. Thus, the inducible binding characteristics of the K3 binding factor(s) are entirely concordant with the requirements for induction of TNF-o~ gene transcription.
As an internal control for specificity of binding and protein loading in the experiments displayed in Fig. 7 , we tested the same nuclear extracts in an EMSA using an oligonucleotide spanning the sequences -61 to -26 n relative to the TNF-c~ mtLNA cap site (-61 to -27 n) as a probe. As expected from the functional data demonstrating that these sequences were not primarily involved in the o~CD3 CsAsensitive induction of the TNF-ol gene, the expression of a constitutive factor binding these sequences were not increased by o~CD3, or affected by treatment with CsA or protein synthesis inhibitors (data not shown). Therefore, the inducible CsA-sensitive binding activity in these nuclear extracts was detected specifically using the K3 oligonucleotide as a probe. Furthermore, the SP1 binding motif that occurs within the sequences spanning -61 to -27 n was shown to be involved in the constitutive binding to the -61 to -27 n probe as an excess of nonradiolabeled wild-type oligonucleotide competed for binding, whereas an oligonucleotide containing a mutation in the Sp1 site did not (data not shown). Thus, the sequences spanning -61 to -27 n specifically bind to a constitutive factor that may be Sp1.
Ca 2+ Ionophore. Nuclear extracts from At-5 cells that had been stimulated with the calcium ionophore ionomycin for 15 min were also tested for the presence of g3 binding activity. As demonstrated in Fig. 8 A, the inducible upper and lower x3 binding complexes were apparent in nuclear extracts from cells treated with 1/~M of ionomycin but not in nuclear extracts from uninduced cells (Fig. 8, lanes I and  2) . A lower concentration of ionomycin (100 nM) slightly induced the lower complex (Fig. 8, lane 3) . The equivalence of protein loading and the specificity of ~c3 inducible binding was confirmed by using the same extracts to bind to the -61 to -27 n probe (Fig. 8, lanes 4-6) .
Furthermore, ionomycin-mediated induction of the upper and lower g3 binding complexes was blocked by CsA (Fig.  8 B, compare lanes 2 and 4) and was unaffected by protein synthesis inhibitors (Fig. 8, lane 6) . Again the -61 to -27 n probe bound to a constitutive factor whose binding was unaffected under these conditions (Fig. 8, lanes 7-12) . Thus, as in the case with c~CD3 induction, ionomycin-inducible binding of the K3 binding factor(s) paralleled TNF-o~ mRNA induction by ionomycin.
Characterization of the/c3 Binding Factor(s)
The Jc3 Binding Factor Is Distinct from NF-/cB but May Resemble NFAT. To establish that the inducible K3 binding complexes bound specifically to the x3 sequence, the ability of nuclear extracts from stimulated T cells to bind to the radiolabeled K3 oligonucleotide in the presence of an excess of unlabeled ~3 competitor oligonudeotide was tested. Unlabeled K3 oligonudeotide competed for binding to both the upper and lower complexes (Fig. 9, lanes I-2) , whereas oligonucleotides corresponding to the two other NF-gB consensus sites in the TNFoc~ promoter, K1 and K2, which are not involved in the induction and CsA sensitivity of the gene (see Fig. 3 ), did not compete for binding (Fig. 9, lanes 3 and 4) .
Previous studies (16) employing human B cell nuclear extracts had demonstrated that K1, K2, and K3 specifically bound a complex that could be competed by an oligonucleotide matching the murine Ig x chain enhancer NF-KB site, but not by an oligonucleotide that was mutated in three guanine residues absolutely required for NF-xB binding. Therefore, whereas K1, x2, ~3, and the Ig K chain enhancer NF-KB site are all capable of binding to the same protein in B cells, the g3 binding factor appears specific for the K3 site alone, consistent with the unique role of this site in the induction of the TNF-c~ gene in activated T cells. Subsequent studies established that ~3 does not form any DNA-protein complex with purified p50/p65 NF-~B (data not shown), indicating that the x3 binding factor is distinct from the p50 homodimer or the pS0/p65 NK-KB heterodimer. The K3 site can bind to proteins in cellular extracts from Ntera cells transfected with c-rel and p50 (54, 55) , however, the complex formed migrates with different mobility from the x3 binding complex (data not shown). Moreover, antibodies to c-tel, pS0, and p65 (56) do not react with the K3 binding complex detected in nuclear extracts from Ar-5 cells stimulated with c~CD3 or ionomydn or from Ar-5 cytosolic extracts (data not shown). We conclude that the g3 binding complex in activated T cells does not contain c-rel, pS0, or p65, and is thus distinct from NF-xB.
Other studies employing nuclear extracts from stimulated T cells showed that an NFAT-like factor bound to the Ig K chain enhancer NF-KB site, and this binding involved residues at the 3' end of the KB site (49) . To determine whether the g3 binding factor might be related to this NFAT-like factor, a competition analysis was done with Ig NF-KB and NFAT oligonucleotides. Oligonucleotides matching the wild-type Ig K chain enhancer NF-KB site (WT), and the NF-xB site from the IFN-~ gene (PRDII) competed for binding of the K3 binding factor. However, an Ig NF-IcB oligonucleotide that was mutated in three guanine residues absolutely required for NF-KB binding (27) also competed for binding to the g3 oligonucleotide (MS', Fig. 9, lane 7) , whereas an oligonucleotide mutated in the 3' residues was no longer able to compete for binding (M3 ~ Fig. 9, lane 8) . This pattern of competition was identical to that seen for the binding of the NFAT related factor to the Ig NF-gB site (49) , and suggested that the K3 binding factor was related to NFAT. Consistent with this, an oligonucleotide matching the distal NFAT site from the murine IL-2 gene promoter competed for binding to the g3 binding factor (Fig. 9, lane 9) .
Methflation Interference Analysis of the Upper and Lower K3 Binding Complexes Suggests that the Same Sequences Required for In Vivo Activity Participate in the Formation of Both Complexes.
To determine whether the upper and lower K3 binding complexes contracted different bases of the x3 oligonucleotide, a methylation interference analysis using nuclear extracts from ionomycin-stimulated Ar-5 cells was performed. Both the 5' and 3' sequences of the site contacted DNA-binding proteins (Fig. 10) . Specifically, methylation of the three guanine residues in the 5' end of the K3 element (relative to the coding strand) substantially interfered with binding of the upper complex (Fig. 10 , compare lane 2 with lanes I and 3), whereas methylation of two of the three guanines in the 3' end of the site eliminated binding of the upper complex (Fig. 10, compare lane 7 to lanes 6 and 8) . For the lower complex, methyhtion of the same 5' and 3' nudeotides resulted in partial interference with binding (Fig. 10, compare lane   4 with lanes 3 and 5 and lane 9 with lanes 8 and 10) . Similar results were obtained using nuclear extracts that had been stimulated with c~CD3 (data not shown). Methylation also interferes with binding to sequences which flank the 5' nucleotides (see noncoding strand, ATGAG), indicating that these sequences may also be involved in the binding of the upper and lower complexes. In conclusion, the same 5' (TGGG) and 3' (CTCC) nudeotides that are crucial for the TCR-and ionophore-mediated induction of the TNF-ol promoter are also crucial for the binding of the upper and lower K3 binding complexes to the g3 oligonucleotide. Moreover, this analysis indicates that both the upper and lower x3 binding complexes bind with similar recognition properties to the g3 oligonucleotide. These complexes may therefore contain the same inducible nudear factor, and the difference in mobility between the two complexes may be due to differential modification and/or association with a different nuclear factor. -10) and methylated. Nuclear extracts from Ar-5 cells that had been induced with 1/~M ionomycin for 30 min were incubated with the methylated probe. Free and bound probes were then isolated, cleaved with piperidine, and analyzed on a 12% denaturing gel. Fragments that are underrepresented in the bound probe as compared to the free probe result from cleavage at guanine residues whose methyhtion interferes with binding. 
The/c3 Binding Factor Preexists in Unstimulated T Cells
The rapid induction of the ~3 binding factor and its independence from de novo protein synthesis suggested that it is present in unstimulated Ar-5 cells. Since specific K3 binding activity was not detected in nuclear extracts from unstimulated At-5 cells (Fig. 7, A and B, lanes I and 2) , cytosolic extracts from unstimulated cells were tested for K3 binding activity. As shown in Fig. 11 , the g3 oligonudeotide specifically bound to a protein(s) in cytosolic extracts from unstimulated Ar-5 cells. The radiolabeled g3 oligonucleotide formed two specific complexes that migrated similarly to those seen when nuclear extracts from stimulated T cells were used (compare to Figs. 7 and 9) . Thus, the g3 binding factor preexists in unstimulated At-5 cells, either sequestered in the cytosol or in an inactive form that can be extracted from the nuclei of unstimulated cells under our extraction conditions. Furthermore, the level of x3 binding factor proteins in the cytosolic extracts decreased by 2>65% after stimulation with ionomycin, and, pretreatment of the cells with CsA blocked this decrease (Fig. 11 B, lanes 1-3) . However, when we employed the -61 to -27 n probe and tested its binding to these extracts, we also detected a decrease in binding after induction by ionomycin (Fig. 11, lanes 4-6) , whereas a probe matching the AP1 site from the murine collagenase gene bound a protein that did not decrease after induction (Fig. 11, lanes  7-9) . The binding complexes formed by the -61 to -27 n and AP1 probes may represent proteins that are leached from the nucleus during the preparation of cytosolic extracts. This is commonly observed for a variety of nuclear proteins including rb (57) and ets proteins (58) . Therefore, although I-3) , the -61 to -27 n oligonucleotide (lanes 4-6) and the AP1 oligonucleotide (lanes 7-9).
we have demonstrated that the g3 binding factor is detected in the cytosolic fraction of unstimulated T cells and appears rapidly in nuclear extracts upon stimulation, we cannot condude definitively that there is a translocation of the K3 binding factor from the cytosol to the nucleus in stimulated T cells. Immunofluorescence experiments using antibodies to purified K3 binding protein will be required to resolve this question.
Discussion
Induction of the Endogenous TNF-cr Gene in Murine T Cells.
We have demonstrated that the TNF-c~ gene is one of the earliest genes induced in T cells activated by TCR ligands. TNF-ol mRNA levels increase strikingly within 15-30 min of exposure of a murine T cell done to activating antibodies against the TCR-CD3 complex. This increase reflects an increase in TNF-e~ gene transcription as judged by the commensurate increase in CAT activity in transient transfection assays using human TNF-o~ promoter CAT fusion plasmids. The transcriptional activation of the TNF-ol gene is not dependent on de novo protein synthesis, since pretreatment of the cells with protein synthesis inhibitors has no effect on the kinetics or magnitude of TNF-c~ mRNA expression. Thus, in contrast to genes encoding most other lymphokines and lymphokine receptors, including IL-2, whose transcription is dependent upon de novo protein synthesis (for reviews see references 59 and 60), the TNF-ot gene behaves as an immediate early gene in activated T cells.
Induction of the TNF-ot gene in Ar-5 T cells is mediated by a calcium-dependent pathway since it occurs in T cells stimulated with calcium ionophore alone. Moreover, induction does not require the ol and B isozymes of protein kinase C, since it occurs efficiently in cells that have been depleted of these isozymes by prolonged treatment with the phorbol ester PDBu (data not shown). These data again differentiate the induction requirements of the TNF-c~ gene from those of other activation-related genes such as IL-2, whose transcription requires both the protein kinase C and calciummediated signals (36, 61) and is abolished by protein kinase C depletion (46, and Goldfeld, A. E., P. G. McCaffrey, and A. Rao, unpublished observations). However, the induction of TNF-c~ gene transcription resembles the induction of other lymphokine genes in that it is completely blocked by the immunosuppressive agents CsA and FKS06.
The/c3 Element Is an crCD3 and Ionophore-inducible Promoter Element in Activated Murine T-cells. The region between -118 and -87 n of the human TNF-oL gene promoter contains a previously identified NF-xB consensus sequence, g3. Sitedirected mutagenesis of x3 within the context of the -199 TNF-o~ promoter decreased but did not obliterate o~CD3 in-duction, suggesting that although K3 is a key element, other sequences participate in TCR-mediated induction of the TNF-c~ promoter. In contrast, ionomycin induction appeared to be primarily mediated through the g3 element as mutation of the 5' or 3' nucleotides almost entirely obliterated the promoter's inducibility. The specificity of this effect is confirmed by the observation that the mutation of other sequences within the promoter did not decrease the promoter's inducibility or CsA sensitivity.
A Preexisting K3 Binding Factor Is a Target for CsA. The protein(s) binding to the K3 element, the K3 binding factor, preexists in unstimulated T cells. Although its location cannot be definitively established in the absence of antibody reagents, it is absent from nuclear extracts of unstimulated T cells, but is present in cytosolic extracts from unstimulated T cells. This indicates that it either normally resides in the cytoplasm of unstimulated cells or that it is extracted from nuclei of unstimulated cells under our extraction conditions. In either case, binding of the K3 binding factor to the g3 element in nuclear extracts requires a modification event that occurs upon T cell activation. It is rapidly detected (within 15 min) in nuclear extracts from T cells stimulated by aCD3 or ionomycin. Furthermore, induction of the g3 binding factor is completely concordant with induction of TNF-c~ gene expression itself: neither process requires de novo protein synthesis and both can be totally blocked by pretreatment with CsA. Taken together, these data suggest that TCR stimulation and the ensuing increase in intracellular calcium activate the ~c3 binding factor by causing its posttranslational modification and/or translocation to the nucleus, and that the nuclear K3 binding complex participates in TNF-o~ gene induction. The rapid disappearance of the K3 binding factor from nuclear extracts after induction may reflect its recycling back to the cytoplasm, inactivation, or degradation. The g3 element thus represents a novel cyclosporin-sensitive regulatory element and the first example characterized in a gene other than IL-2.
Relationship of the/c3-Binding Factor to other Transc@tion Factors. Despite the resemblance of the K3 element to an NF-KB binding site (16) , the p50/p65 NF-~cB heterodimer and/or c-rel are not part of the ~c3 binding complex. First, the K3 element does not bind to purified pS0/p65 NF-gB in an EMSA. Second, the appearance of the p50/p65 NF-KB heterodimer in nuclear extracts of activated Ar-5 T cells is not inhibited by CsA at 30 min after activation, and is only partially inhibited at 2 h (49, and McCaffrey, P. G., and A. Rao, unpublished results). In contrast, the nuclear induction of the K3 binding complex is completely blocked by CsA in all time points tested. Third, an oligonucleotide that is mutated in the 5' guanines crucial for binding of the pS0/p65 NF-KB heterodimer competes for binding to the g3 binding factor. Finally, antibodies to p50, p65, or c-tel have no effect on the mobility of the K3 binding complex. Thus, the K3 binding factor is distinct from p50/p65 NF-gB and does not contain c-rel.
The K3 binding factor is dearly distinct from the factors oct-1 and OAP-40 (44) , which bind to the NFIL2A site of the IL-2 promoter. Although the induction of multimers of the NFIL2 site is blocked by CsA and FKS06 (37) , their maximal induction requires stimulation with both phorbol ester and ionophore, whereas the g3 multimer constructs are inducible by ionomycin alone. The oct-1 protein is constitutively expressed in nuclear extracts of unstimulated T cells and its binding is not affected by CsA or FK506 (37) . Furthermore, the octamer-associated protein OAP-40, although inducible in a gel shift assay, requires protein synthesis for its induction (44) . The relationship of the K3 binding factor to the factor binding to the NFAT site of the ILo2 promoter remains to be elucidated. This factor, also termed NFAT, consists of a preexisting subunit (NFATp) present in cytosolic extracts of unstimulated T cells (41) (42) (43) 62) , which associates with los and jun proteins in the nuclei of activated T cells (42) . The preexisting NFATp subunit resembles the g3 binding factor in that its appearance in nuclear extracts of activated T cells can be induced with calcium ionophore, does not require de novo protein synthesis, and is completely blocked by CsA (41) (42) (43) (62) (63) (64) . Previous studies have shown that NFATp is a substrate for calcineurin, the serine/threonine phosphatase whose activity is inhibited by CsA-cyclophilin and FKS06-FKBP complexes (43) . The data presented here indicate that the g3 binding factor may also be a calcineurin substrate.
The NFAT site shares no clear sequence similarity with the K3 element, other than being pyrimidine rich. However, factors related to NF-ATp are capable of binding to several NF-gB sequence motifs (49) , and we have shown that the murine IL-2 NFAT oligonucleotide is able to compete with g3 for binding. It is therefore possible that the K3 binding factor may be a member of a closely related family of transcription factors resembling NF-ATp, that undergo a shared calcium-dependent, CsA-sensitive posttranslational modification step. Alternatively, NFATp itself could be a part of the K3 binding complex.
In conclusion, the TNF-c~ gene represents a new model system for the study of those signal transduction events after T cell activation that results in CsA-sensitive inducible gene transcription. The protein product of the TNF-a gene cooperates in the differentiation and proliferation of B and T cells (4, 5, 65) , the generation of dendritic Langerhans cells (66) , and is capable of inducing latent HIV-1 into a productive infection (7, 67) . Recent studies have demonstrated that TNF-a plays a critical role in superantigen-triggered lethal shock mediated by T cells (68) , and elevated TNF-a levels are associated with renal and cardiac allograft rejection (69, 70) and several infectious diseases (71) . Therefore, in addition to providing insight into the molecular events that follow lymphocyte activation, and mechanisms of inducible gene transcription, these studies could have a practical impact upon the modulation by immunosuppressants of TNF-oe levels in transplant medicine, lymphoproliferative disorders, and other disease states.
